Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
1.260
+0.010 (0.80%)
At close: Jun 12, 2026, 4:00 PM EDT
1.270
+0.010 (0.79%)
After-hours: Jun 12, 2026, 4:04 PM EDT
Tempest Therapeutics Market Cap
Tempest Therapeutics has a market cap or net worth of $18.07 million as of June 12, 2026. Its market cap has decreased by -19.93% in one year.
Market Cap
18.07M
Enterprise Value
24.12M
1-Year Change
-19.93%
Ranking
Category
Stock Price
$1.26
Market Cap Chart
Since June 28, 2021, Tempest Therapeutics's market cap has decreased from $88.65M to $18.07M, a decrease of -79.61%. That is a compound annual growth rate of -27.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 18.07M | 27.81% |
| Dec 31, 2025 | 14.14M | -61.17% |
| Dec 31, 2024 | 36.42M | -57.00% |
| Dec 29, 2023 | 84.69M | 600.22% |
| Dec 30, 2022 | 12.09M | -66.85% |
| Dec 31, 2021 | 36.49M | -58.84% |
| Jun 28, 2021 | 88.65M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pasithea Therapeutics | 19.39M |
| Traws Pharma | 18.94M |
| AEON Biopharma | 18.68M |
| Cellectar Biosciences | 18.06M |
| Werewolf Therapeutics | 17.74M |
| Exicure | 17.59M |
| Curis | 17.34M |
| CEL-SCI | 17.10M |